Back to Search Start Over

Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D 2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with 18 F-MNI-659 and 11 C-raclopride with correction for partial volume effect.

Authors :
Fazio P
Schain M
Mrzljak L
Amini N
Nag S
Al-Tawil N
Fitzer-Attas CJ
Bronzova J
Landwehrmeyer B
Sampaio C
Halldin C
Varrone A
Source :
NeuroImage [Neuroimage] 2017 May 15; Vol. 152, pp. 330-339. Date of Electronic Publication: 2017 Feb 28.
Publication Year :
2017

Abstract

Phosphodiesterase 10A enzyme (PDE10A) is an important striatal target that has been shown to be affected in patients with neurodegenerative disorders, particularly Huntington´s disease (HD). PDE10A is expressed on striatal neurones in basal ganglia where other known molecular targets are enriched such as dopamine D <subscript>2/3</subscript> receptors (D <subscript>2/3</subscript> R). The aim of this study was to examine the availability of PDE10A enzyme in relation with age and gender and to compare those changes with those related to D <subscript>2/3</subscript> R and volumes in different regions of the basal ganglia. As a secondary objective we examined the relative distribution of D <subscript>2/3</subscript> R and PDE10A enzyme in the striatum and globus pallidus. Forty control subjects (20F/20M; age: 44±11y, age range 27-69) from an ongoing positron emission tomography (PET) study in HD gene expansion carriers were included. Subjects were examined with PET using the high-resolution research tomograph (HRRT) and with 3T magnetic resonance imaging (MRI). The PDE10A radioligand <superscript>18</superscript> F-MNI-659 and D <subscript>2/3</subscript> R radioligand <superscript>11</superscript> C-raclopride were used. The outcome measure was the binding potential (BP <subscript>ND</subscript> ) estimated with the two-tissue compartment model ( <superscript>18</superscript> F-MNI-659) and the simplified reference tissue model ( <superscript>11</superscript> C-raclopride) using the cerebellum as reference region. The PET data were corrected for partial volume effects. In the striatum, PDE10A availability showed a significant age-related decline that was larger compared to the age-related decline of D <subscript>2/3</subscript> R availability and to the age-related decline of volumes measured with MRI. In the globus pallidus, a less pronounced decline of PDE10A availability was observed, whereas D <subscript>2/3</subscript> R availability and volumes seemed to be rather stable with aging. The distribution of the PDE10A enzyme was different from the distribution of D <subscript>2/3</subscript> R, with higher availability in the globus pallidus. These results indicate that aging is associated with a considerable physiological reduction of the availability of PDE10A enzyme in the striatum. Moreover as result of the analysis, in the striatum for both the molecular targets, we observed a gender effect with higher BP <subscript>ND</subscript> the female group.<br /> (Copyright © 2017 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1095-9572
Volume :
152
Database :
MEDLINE
Journal :
NeuroImage
Publication Type :
Academic Journal
Accession number :
28254508
Full Text :
https://doi.org/10.1016/j.neuroimage.2017.02.047